束缚应激大鼠血清淋巴细胞转化抑制因子的研究

为研究应激对淋巴细胞转化的影响,将 SD 大鼠四肢束缚于支架上,仰卧位,室温(20℃)下维持20h,对照组留置原饲养笼中,不予惊动。然后在乙醚轻麻下穿刺心脏取血,肝素化后密度梯度离心分离淋巴细胞,或待凝后分离血清。结果表明,应激大鼠外周血淋巴细胞对刀豆素(Con A)诱导的转化反应明显下降(p<0.01,n=8,ANOVA),而且应激大鼠血清可明显抑制正常小鼠淋巴细胞转化,这提示应激大鼠血清中可能存在某种具有抑制淋巴细胞转化的活性物质。进一步的分析实验表明,这种血清经加热56℃(30min),30%甲醇或透析(透析袋孔径阻滞分子量为6000)处理,抑制活性均不受影响;但经加热100℃(3min),80%甲醇或胰蛋白酶(64/μg/ml)处理,抑制活性丧失。提示这种抑制活性物质很可能是一类蛋白质。     

蛋白激酶C对大鼠支气管平滑肌KV通道的影响

用全细胞膜片钳、Western印迹法和逆转录—PCR技术,观察蛋白激酶C(protein kinase C,PKC)对大鼠支气管平滑肌细胞(bronchial smooth muscle cells,BSMCs)电压依赖性延迟整流钾通道(Kv)活性及其亚型Kvl．5表达的影响。结果为：(1)PKC激活剂豆蔻酰佛波醇乙酯(phorbol 12-myristate 13-acetate,PMA)显著抑制急性分离大鼠BSMCs的Kv通道电流,该效应被PKC阻断剂Ro31—8220显著抑制;(2)PMA显著抑制体外培养大鼠BSMCs的Kvl．5 mRNA和蛋白质的表达,该效应被Ro31—8220显著抑制。上述观察结果提示,PKC活化可抑制大鼠BSMCs的Kv通道电流活性,下调Kvl．5亚型的表达水平。     

束缚应激动物血清中免疫抑制因子产生部位的初步研究

大鼠或小鼠经束缚应激10h后,血清中出现一类淋巴细胞转化抑制因子。本实验在上述工作的基础上对抑制因子的产生部位做了初步研究,结果表明,应激后脑脊液中不存在淋巴细胞转化抑制因子,说明这种因子不是由中枢神经系统产生。大剂量辐射与环磷酰胺均能降低脾脏有核细胞总数,但前者能降低抑制因子的产生,后者无作用,提示淋巴细胞总数的减少对血清抑制因子的产生可能不起决定性作用。细胞分类的结果表明,辐射能明显降低T、B细胞比例,而环磷酰胺反而使其比例有上升趋势。因而提示抑制因子的产生可能与T、B淋巴细胞的比例有关。当T细胞比例减少时,抑制因子的产生受到阻碍。裸鼠为先天性T细胞功能缺失动物,同样的应激条件抑制因子的产生受到明显抑制。这也说明抑制因子的产生可能与T细胞的作用有关。     

佛波酯诱导大鼠滑膜细胞骨架改变的研究

以体外培养的大鼠关节炎模型的滑膜细胞为研究对象,用蛋白激酶C(PKC)激活剂佛波酯(phorbol 12-myristate 13-acetate, PMA)刺激细胞模拟炎症过程,应用原子力显微成像技术研究了大鼠滑膜细胞在PKC活化后细胞骨架变化情况．结果表明,利用原子力显微镜成像可以较好地表征PMA刺激引起滑膜细胞骨架的收缩隆起及细胞表面质地的变化,并揭示了PKC活化可能是引起滑膜细胞骨架改变的重要原因．这些结果为加深了解类风湿关节炎的发生机制提供了实验基础．     

淋巴细胞活化基因-3敲除(Lag-3~(-/-))小鼠构建及初步表型分析

目的构建淋巴细胞活化基因-3(Lag-3)基因敲除小鼠,初步分析Lag-3基因敲除对小鼠表型影响,为后续Lag-3体内功能研究提供动物模型。方法利用CRISPR/Cas9技术结合受精卵显微注射构建敲除小鼠,通过分子鉴定筛选基因敲除阳性小鼠,利用RT-PCR和流式检测方法进一步验证Lag-3基因敲除小鼠体内Lag-3基因敲除效果;通过建立Con A诱导的肝损伤模型研究Lag-3基因在体内的功能。结果 PCR和产物测序结果显示,获得了exon 2缺失的Lag-3基因敲除小鼠;该基因敲除纯合子小鼠(Lag-3~(-/-))经刀豆蛋白(Con A)刺激后,小鼠心脏、脾、肺、巨噬细胞和淋巴结中仅能检测到Lag-3 mRNA本底表达信号,小鼠巨噬细胞、脾细胞和淋巴结中仅能检测到非常低数量的Lag-3阳性细胞。表型分析发现,Lag-3基因的缺失显著减少了Con A诱导的小鼠外周血、骨髓和脾CD3+T细胞的数量,减轻了Con A诱发的急性肝损伤情况。结论成功构建Lag-3基因敲除小鼠模型,肝损伤过程中的体内功能研究显示,Lag-3缺失可以显著缓解Con A引发的肝损伤的发生。     

Con A刺激致T淋巴细胞胞浆游离Ca~(2 )浓度升高

本文分别应用荧光Ca~(2 )指示剂Quin2和Indo-1研究了Con A刺激的T淋巴细胞[Ca~(2 )]i升高过程及其发生机制.结果表明Con A与T淋巴细胞作用可导致细胞[Ca~(2 )]i的迅速升高.这种增加的胞内游离Ca~(2 )不仅来自胞外Ca~(2 )的内流,也来源于胞内钙库的释放.其中Ca~(2 )内流与T细胞钙通道的开放有关.可被钙通道抑制剂戊脉胺抑制,细胞的去极化及钾通道阻断剂四乙胺均不能阻断Ca~(2 )的内流,提示Ca~(2 )内流不是通过电位操纵的钙通道实现的,也与拥通道的开闭无关.Ca~(2 )内流可能是通过Con A受体活化的受体操纵的钙通道而实现的.     

PKC-ERK通路在热损伤诱导单核细胞凋亡中的作用

应用流式细胞检测术、Western印迹、激酶活性测定等技术,检测PKC与ERK在热损伤诱导单核细胞株Raw264.7细胞凋亡中的作用。结果显示热损伤导致PKC短暂激活,PKC激活剂佛波脂(PMA)与热损伤联合作用导致PKC持续活化;并且PKC的持续激活抑制热损伤诱导的Raw264.7细胞凋亡,而PKC的抑制可促进细胞凋亡;ERK活性检测显示热损伤抑制ERK磷酸化,而PMA激活ERK磷酸化活化,并且这种激活作用通过PKC;进一步细胞凋亡检测显示ERK抑制剂PD098059可解除PMA对热损伤诱导Raw264.7细胞凋亡的抑制作用,从而提示PKC通过ERK负调控热损伤诱导的Raw264.7细胞凋亡。     

肿瘤宿主的免疫状态 Ⅲ.带Ehrlich实体瘤小鼠脾脏细胞在体外对肿瘤细胞的细胞静止效应的动态观察

应用5-~(125)碘-2’-脱氧尿嘧啶核苷(~(125)IUdR)参入抑制试验,证明带Ehrlich实体瘤的C57BL 小鼠脾脏细胞可在体外对同一移植肿瘤细胞的DNA 合成产生显著的抑制。随着肿瘤的增长,带瘤小鼠的脾脏进行性增大,脾细胞对肿瘤细胞的抑制效应也随之增强。这种对肿瘤细胞DNA合成的抑制作用是非特异的。肿瘤切除后,抑制效应也随之下降,到术后21天,细胞静止效应已不能测得。本文还应用~(125)IUdR技术同时测定了带瘤小鼠脾脏的T 杀伤细胞,脾脏淋巴细胞对致分裂原Con A 与PWM 的转化反应的动态变化,实验表明带瘤小鼠脾脏T、B 淋巴细胞的功能是受抑制的。组织病理学观察提示,带瘤动物脾脏的网织细胞和巨噬细胞的增多可能与细胞静止效应的增强有关。     

小脑间位核对淋巴细胞功能的调节作用

目的:研究小脑深部核团之一间位核对淋巴细胞功能的调节作用,以拓宽对小脑功能的认识进而增加神经免疫学的知识.方法:在大鼠双侧小脑间位核内注射海人酸(KA)以损毁间位核内神经元的胞体,并设对照组,于小脑间位核内注入等量生理盐水.在手术后的第8、16、32 d分别用血细胞计数法检测动物外周血中淋巴细胞的数量;用四甲基偶氮唑(MTT)比色法检测动物肠系膜淋巴结细胞对刀豆蛋白A(Con A)刺激的增殖反应;用ELISA法检测动物血清中抗绵羊红细胞(SRBC)特异性IgM抗体的生成能力;用流式细胞术测定脾脏自然杀伤(NK)细胞的活性.结果:小脑间位核损毁后的第8、16、32 d,动物外周血中淋巴细胞数都明显低于损毁手术前的淋巴细胞数,也显著低于生理盐水对照组相应时间段的淋巴细胞数.在小脑间位核注射KA后的第8、16、32 d,动物的肠系膜淋巴结细胞由Con A诱导的增殖反应、血清中特异性抗SRBC IgM抗体的生成能力和脾脏NK细胞杀伤靶细胞YAC-1的活性均明显低于生理盐水对照组,但比较损毁后不同时间段的T、B和NK细胞功能的变化,没有发现显著的差异.结论:小脑双侧间位核损毁可导致总淋巴细胞数以及T、B和NK细胞功能均发生不可逆的降低,充分说明小脑间位核可调节淋巴细胞的功能,并提示在正常体内,小脑间位核对淋巴细胞功能具有增强效应.     

电剌大鼠的血清中淋巴细胞转化抑制因子的作用机制分析

Previous reports showed that EA stimulation (3V, 2Hz, 30 min/d, 5 d) induced the production of one or more lymphocyte proliferation-inhibitory factor(s) in the rat serum. In this paper, the mechanisms of the action for the inhibitory factor(s) to suppress lymphocyte proliferation were studied. (1) the lymphocytes from different immune organs of the mice were prepared and cultured with the rat serum stimulated by EA. The results show that the serum not only inhibited the mouse lymph node T cell proliferation induced by Con A, but also inhibited the mouse thymocyte and spleen T cell proliferation induced by Con A. When B cells were stimulated by LPS, the proliferative effect can also be inhibited significantly by the rat serum stimulated by EA. This implies that the effect of the lymphocyte proliferation-inhibitory factor(s) has no specificity. (2) Incubation of the mouse lymph node cell with serum for one hour is enough to cause an inhibitory effect on Con A stimulated lymphocyte proliferation. However, no inhibitory effect was observed if the mouse lymph node cells were incubated with Con A for 15 min or 30 min before the addition of rat serum. The results demonstrate that the lymphocyte proliferation-inhibitory factor(s) act on the early events of T lymphocyte activation induced by Con A. (3) Protein kinase C (PKC) is a key link in the activation of T and B lymphocyte proliferation by Con A and LPS respectively. So it would be interesting to learn whether the inhibitory effect of the lymphocyte proliferation-inhibitory factor(s) is caused by the inhibition of PKC activity.(ABSTRACT TRUNCATED AT 250 WORDS)     

Magnetic field inhibits isolated lymphocytes' proliferative response to mitogen stimulation

We aimed to find out how the exposure of isolated lymphocytes to a pulsed magnetic field (MF) affected their in vitro proliferative response to mitogenic stimulation. Cells were exposed to MF of various intensities (0.3, 0.6, and 1.2 T) at a constant frequency of 30 Hz, for a period of 60, 180, and 330 s. Then, the proliferative response of splenocytes was induced by optimal concentrations of concanavalin A (Con A; mitogenic toward T cells), bacterial lipopolysaccharide (LPS; mitogenic toward B cells), or pokeweed mitogen (PWM; mitogenic toward both populations). We found that the exposure of lymphocytes to the MF profoundly inhibited their proliferative response to mitogens. The suppressive action of the MF on B and T cell proliferation was intensified when a cooperative response of those two lymphocyte populations was simultaneously induced by PWM. The inhibitory effect of MF depended on the exposure time and MF intensity. Prolonged exposure and/or a stronger intensity of the MF weakened its inhibitory influence on the response of lymphocyte to mitogenic stimulation. The data show that an exposure to MF may influence the activity of lymphocytes in their response to mitogenic stimuli.     

Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses

Stimulated T cell-derived inhibitory factor for cellular DNA synthesis (STIF), a lymphokine produced from concanavalin A (Con A)-stimulated rat suppressor T cells, was examined for its inhibitory effect on various cultured cells and on in vitro immune reactions. STIF could inhibit the DNA synthesis of a variety of normal and neoplastic cells from rats, mice, and humans in a dose-dependent fashion. Kinetics studies revealed that STIF selectively inhibited cellular DNA synthesis after incubation for 12 hr, but after 36 hr, it also inhibited RNA and protein syntheses. The inhibited cellular DNA synthesis by 12-hr incubation with STIF was recovered after culturing the cells in STIF-free medium. The inhibitory effect of STIF on the DNA synthesis was not blocked by addition of a sugar (alpha-methyl-D-mannoside, N-acetyl-D-glucosamine, N-acetyl-D-galactosamine, L-fucose, or L-rhamnose) in culture, as determined by using rat bone marrow cells. STIF inhibited proliferative responses of rat lymphocytes to T cell mitogens, Con A and phytohemagglutinin, and a B cell mitogen, lipopolysaccharide, as well as IL 2-dependent growth of cloned T572 cells. It could also inhibit both blastogenesis and cytotoxic T cell generation in allogeneic mixed lymphocyte reaction. The release of IL 2 from Con A-stimulated T cells was also inhibited by the added STIF in culture, as demonstrated from the finding that IL 2 activity was not detected in the supernatants even after an anion-exchange column chromatography. These results indicate that STIF could inhibit cellular DNA synthesis in a species-unrestricted manner and thus inhibits the proliferation of various normal and neoplastic cells, and that it could also inhibit lectin- or IL 2-dependent T cell proliferation as well as IL 2 production from T cells in in vitro immune reactions.     

LFA-1/ICAM-1在ConA诱导的小鼠胸腺细胞活化中的作用

用抗LFA-1/ICAM-1粘附分子单克隆抗体和ConA联合刺激小鼠胸腺细胞,初步研究了该膜分子在经TCR/CD3介导的胸腺细胞活化信号传导以及胸腺细胞亚群选择中的作用。在ConA刺激系统中,抗ALFA-1/ICAM-1单抗均能抑制胸腺细胞的增殖应答,且以抗LFA-1单抗的作用更为显著;而在PMA加钙离子载体A23187刺激体系中,抗LFA-1单抗却表现出明显的促活化效应。当加入IL-2 时,抗LFA——1/ICAM-1单抗便不能抑制ConA刺激的胸腺细胞活化。此外,抗体对已活化的胸腺母细胞增殖也无影响。FACS分析的结果还显示,抗LFA-1单抗可明显降低CD4~-CD8~ 胸腺细胞亚群的比例,而抗ICAM-1单抗对此无影响。表明胸腺细胞表面粘附分子LFA-1具有直接参与TCR/CD3途径介导的跨膜信号传导的功能,并对CD4~-CD8~ 胸腺细胞亚群的功能分化与成熟可能起重要作用。     

Fluoxetine Action on Murine T-Lymphocyte Proliferation: Participation of PKC Activation and Calcium Mobilisation

The present study was undertaken to analyse the effect of fluoxetine upon murine T-lymphocyte proliferation. We found that fluoxetine exerted a dual effect, which depended on the degree of lymphocyte activation: at mitogenic concentration (2 μg/mL) of concavalin A (Con A), we observed an inhibitory effect on cellular proliferation, whereas, on submitogenic Con A concentration (1 μg/mL), fluoxetine stimulated the cellular response. Given these facts, we studied PKC activation and calcium mobilisation in both stimulatory and inhibitory effects of fluoxetine on T-cell proliferation. We observed that fluoxetine increased PKC translocation obtained with 1 μg/mL Con A concentration, whereas PKC was degraded when 2 μg/mL was used. This mechanism is thought to be mediated by calcium mobilisation. According to our results, fluoxetine seemed to modulate calcium influx, which, in turn, would influence PKC translocation, modulating the immune response.     

Characterization of Cell Growth-Inhibitory Factor in Inflammatory Peritoneal Exudate Cells of Rats

We characterized the nature and reaction mode of the cell growth-inhibitory factor (here designated CGIF) from rat peritoneal exudate cells (PEC). The soluble fraction separated from the lysate of Enterococcus faecalis-induced 24 hr PEC completely inhibited Con A-induced thymocyte mitogenesis. Gel filtration chromatography showed that CGIF has a molecular weight of approximately 23–25 kDa. Isoelectric focusing with Rotofor indicates that the factor has an isoelectronic point of 5.8–6.4. CGIF was inactivated by treatment at 70 C, for 30 min or by tryptic digestion, but the activity was not destroyed by the reduction with dithiothreitol. As well as thymocyte proliferation, CGIF completely suppressed ³H-thymidine incorporation of splenocytes which were stimulated by either Con A or LPS, suggesting the factor is effective on both T and B cells. The acting point of the inhibitor appeared to be a later stage of the lymphocyte activation sequence, since it was still effective when added 28.5 hr after the addition of Con A. CGIF also reduced the viability of these cells when added with mitogens such as Con A or LPS. CGIF thus appears to be distinct from interleukin-1 receptor antagonist or transforming growth factor-β.     

Study of the possibility to abolish the action of immunosuppressive factors of tumor cells]

We investigated the efficacy of IL-2, LPS, MDP, TRA, ionomycin and contrykal on proliferation of lymphocytes treated by tumor cell immunosuppressive factors (ISF). IL-2, LPS and/or MDP did not abolish the influence of P815 and B16 ISF on Con A or alloantigen-induced lymphocyte proliferation. TPA and in less extent ionomycin and combination of the above preparations totally abrogated the suppression of Con A-induced lymphocyte proliferation. In inverted experiments Con A abrogated ISF-mediated suppression of lymphocyte proliferation induced by TPA plus ionomycin.     

The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation

T lymphocyte infiltration into inflamed tissues is thought to involve lymphocyte rolling on vascular endothelial cells. Because both selectin and alpha(4) integrin adhesion molecules can mediate leukocyte rolling, the contribution of these receptors to lymphocyte migration to inflammation was examined. The recruitment of (111)In-labeled spleen T cells to intradermal sites injected with IFN-gamma, TNF-alpha, LPS, poly inosine-cytosine, and Con A was measured in the rat, and the effect of blocking mAbs to E-selectin, P-selectin, very late activation Ag-4 (VLA-4), and LFA-1 was determined on this T cell migration in vivo. Anti-E-selectin and anti-P-selectin mAbs each inhibited 10-40 and 20-48%, respectively, of the T lymphocyte migration to the inflammatory sites, depending on the stimulus. Blocking VLA-4 inhibited 50% of the migration to all of the lesions except Con A. Treatment with both anti-VLA-4 and anti-E-selectin mAbs inhibited up to 85% of the lymphocyte accumulation, while P-selectin and VLA-4 blockade in combination was not more effective than VLA-4 blockade alone in TNF-alpha, IFN-gamma, LPS, and poly inosine-cytosine lesions. Inhibiting E-selectin, P-selectin, and VLA-4 together nearly abolished lymphocyte migration to all inflammatory sites. Anti-LFA-1 mAb strongly inhibited lymphocyte accumulation by itself, and this inhibition was not significantly further reduced by E- or P-selectin blockade. Thus, T cell migration to dermal inflammation is dependent on E-selectin, P-selectin, and VLA-4, likely because these three receptors are required for rolling of memory T lymphocytes, but VLA-4 and E-selectin are especially important for lymphocyte infiltration in these tissues.     

Potentiation of the T lymphocyte response to mitogens. V. Inhibition of the response to concanavalin A by supraoptimal doses or by other lectins and its aversion by LAF.

The enhanced thymidine incorporation in murine lymphocytes induced by Concanavalin A (Con A) was markedly inhibited in the presence of other lectins, which are poorly mitogenic (phytohemagglutinin {PHA} or pokeweed mitogen), or non-mitogenic (soybean agglutinin {SBA}). The level of inhibition was found to be inversely proportional to the mitogenic effect of the lectins. Our results did not support the notions that the lectins inhibit the lymphocyte responses by competing with Con A, or by activating suppressor cells. Rather, the data suggest that the lectins cause cytotoxic or cytostatic effects. The effects of the inhibitory lectins were found to resemble those of supraoptimal doses of Con A. In particular, both effects were partly averted by the lymphocyte activating factor (LAF). The mitogenic effect of LAF was not inhibited by the non-mitogenic lectin, SBA, whereas the poor responses to PHA or to moderately supraoptimal doses of Con A were markedly potentiated by this factor. It is thus suggested that LAF activity counteracts the inhibitory processes provoked by the lectins.     

Interactions between neuropeptides and dexamethasone on the mitogenic response of rabbit spleen lymphocytes.

The interactions between vasoactive intestinal peptide (VIP), substance P (SP), a somatostatin analog (SMS 201-995) and dexamethasone have been investigated on the Con A mitogenic response of rabbit spleen cells. The neuropeptide regulatory effects appeared to be time dependent: when added with the Con A mitogen, they inhibited (VIP) or did not modulate (SMS and SP) the rabbit lymphocyte proliferation and did not change the inhibitory effect induced by a dexamethasone preincubation. When added 18 h before the mitogen, they all induced an increase of the proliferative response at high concentration. The mitogenic response observed when adding dexamethasone to lymphocytes previously preincubated in the presence of neuropeptides was not different from control response except with SMS 10(-10) M. The similar lymphocyte responses obtained whatever the neuropeptide suggested that the immunomodulatory effect induced by a neuropeptide preincubation might be mediated by the induction of common effector(s).